BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11279350)

  • 1. Diagnosis of papillary thyroid carcinoma is facilitated by using an RT-PCR approach on laser-microdissected archival material to detect RET oncogene activation.
    Lahr G; Stich M; Schütze K; Blümel P; Pösl H; Nathrath WB
    Pathobiology; 2000; 68(4-5):218-26. PubMed ID: 11279350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
    Liu RT; Chou FF; Wang CH; Lin CL; Chao FP; Chung JC; Huang CC; Wang PW; Cheng JT
    Thyroid; 2005 Apr; 15(4):326-35. PubMed ID: 15876154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material.
    Williams GH; Rooney S; Thomas GA; Cummins G; Williams ED
    Br J Cancer; 1996 Aug; 74(4):585-9. PubMed ID: 8761374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
    Cinti R; Yin L; Ilc K; Berger N; Basolo F; Cuccato S; Giannini R; Torre G; Miccoli P; Amati P; Romeo G; Corvi R
    Cytogenet Cell Genet; 2000; 88(1-2):56-61. PubMed ID: 10773666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.
    Rhoden KJ; Johnson C; Brandao G; Howe JG; Smith BR; Tallini G
    Lab Invest; 2004 Dec; 84(12):1557-70. PubMed ID: 15502856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.
    Puxeddu E; Moretti S; Giannico A; Martinelli M; Marino C; Avenia N; Cristofani R; Farabi R; Reboldi G; Ribacchi R; Pontecorvi A; Santeusanio F
    Eur J Endocrinol; 2003 May; 148(5):505-13. PubMed ID: 12720532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
    Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
    Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
    Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas.
    Lee CH; Hsu LS; Chi CW; Chen GD; Yang AH; Chen JY
    J Clin Endocrinol Metab; 1998 May; 83(5):1629-32. PubMed ID: 9589668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
    Tallini G; Santoro M; Helie M; Carlomagno F; Salvatore G; Chiappetta G; Carcangiu ML; Fusco A
    Clin Cancer Res; 1998 Feb; 4(2):287-94. PubMed ID: 9516913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
    Elisei R; Romei C; Vorontsova T; Cosci B; Veremeychik V; Kuchinskaya E; Basolo F; Demidchik EP; Miccoli P; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3211-6. PubMed ID: 11443191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
    Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
    Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.
    Fusco A; Chiappetta G; Hui P; Garcia-Rostan G; Golden L; Kinder BK; Dillon DA; Giuliano A; Cirafici AM; Santoro M; Rosai J; Tallini G
    Am J Pathol; 2002 Jun; 160(6):2157-67. PubMed ID: 12057919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
    Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
    Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
    Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ret/PTC chimeric transcripts in an Irish cohort of sporadic papillary thyroid carcinoma.
    Finn SP; Smyth P; O'Leary J; Sweeney EC; Sheils O
    J Clin Endocrinol Metab; 2003 Feb; 88(2):938-41. PubMed ID: 12574236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
    Smida J; Salassidis K; Hieber L; Zitzelsberger H; Kellerer AM; Demidchik EP; Negele T; Spelsberg F; Lengfelder E; Werner M; Bauchinger M
    Int J Cancer; 1999 Jan; 80(1):32-8. PubMed ID: 9935226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
    Lam KY; Lo CY; Leung PS
    Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
    Powell DJ; Russell J; Nibu K; Li G; Rhee E; Liao M; Goldstein M; Keane WM; Santoro M; Fusco A; Rothstein JL
    Cancer Res; 1998 Dec; 58(23):5523-8. PubMed ID: 9850089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.